However, Sopik et al. [29] employed a comprehensive research approach encompassing various study types, suggesting an increased CRC risk within individuals carrying BRCA1/2 mutations in high-risk familial contexts. The gene discussed is BRCA1; the disease is colorectal carcinoma.